Dallas, TX -- (SBWIRE) -- 11/14/2010 -- SandlerResearch announce Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, “Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Alzheimer’s disease market. The report identifies the key trends shaping and driving the global Alzheimer’s disease market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Alzheimer’s disease sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData has estimated the global Alzheimer’s disease therapeutics market to be valued at $7.1 billion in 2009. It is expected to decline to $5.2 billion with a Compound Annual Growth Rate (CAGR) of (4%) by 2017. The market structure is projected to change in the near future following the patent expiry of the leading drugs in next 2-3 years. Aricept patent expires in November 2010, Namenda’s (Forest) patent is set to expire in April 2015. There is a high unmet need in the current Alzheimer’s disease market in terms of both safety and efficacy profile
Browse complete report : Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017
Scope
The report provides information on the key drivers and challenges of the Alzheimer’s disease market. Its scope includes:
Annualized global Alzheimer’s disease market revenues data from 2001 to 2009, forecast for eight years to 2017.
Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as of cholinesterase inhibitors, N-methyl D-aspartate, serotonin receptor antagonists, immunotherapy, gamma secretase inhibitors and beta secretase inhibitors.
Analysis of the current and future competition in the global Alzheimer’s disease market. Key market players covered are Pfizer, AstraZeneca, Baxter Healthcare, Elan and Medivation.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Alzheimer’s disease therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global Alzheimer’s disease market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Alzheimer’s disease market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What’s the next big thing in the global Alzheimer’s disease market landscape? – Identify, understand and capitalize.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Alzheimer’s Disease Therapeutics : Introduction 6
2.1 GlobalData Report Guidance 6
3 Alzheimer’s Disease Therapeutics: Market Characterization 7
3.1 Overview 7
3.2 Alzheimer’s Disease Therapeutics Market Size 7
3.3 Alzheimer’s Disease Therapeutics Market Forecast and CAGR 7
3.4 Drivers and Barriers for the Alzheimer’s Disease Therapeutics 9
3.4.1 Drivers for the Alzheimer’s Disease Therapeutics 9
3.4.2 Barriers for the Alzheimer’s Disease Therapeutics Market 9
3.5 Opportunity and Unmet Need 9
3.6 Key Takeaway 10
4 Alzheimer’s Disease Therapeutics: Competitive Assessment 11
4.1 Overview 11
4.2 Strategic Competitor Assessment 11
4.3 Product Profile for the Major Marketed Products in the Alzheimer’s Disease Therapeutics 12
4.3.1 Aricept (donepezil hydrochloride) 12
4.3.2 Exelon (rivastigmine titrate) 13
4.3.3 Namenda (memantine hydrochloride) 15
4.4 Other Marketed Products for Alzheimer’s Disease Therapeutics 16
4.4.1 Cognex 16
4.4.2 Razadyne (galantamine hydrobromide extended release capsules) 17
4.5 Key Takeaway 18
5 Alzheimer’s Disease Therapeutics: Pipeline Assessment 19
5.1 Overview 19
5.2 Strategic Pipeline Assessment 19
5.2.1 Technology Trends Analytical Framework 19
5.3 Alzheimer’s Disease Therapeutics-Promising Drugs Under Clinical Development 20
5.4 Molecular Profile for the Promising Drugs under Clinical Development 21
5.4.1 Bapineuzumab 21
5.4.2 Gammagard 22
5.4.3 Dimebon 23
5.4.4 Rember (Trx0014) (methylthionium chloride) 24
5.5 Alzheimer’s Disease Therapeutics – Clinical Pipeline by Mechanism of Action 25
5.6 Alzheimer’s Disease Therapeutics Pipeline – Pipeline by Clinical Phases of Development 26
5.6.1 Alzheimer’s Disease Therapeutics – Regulatory and Phase III Clinical Pipeline 26
5.6.2 Alzheimer’s Disease Therapeutics – Phase II Clinical Pipeline 27
5.6.3 Alzheimer’s Disease Therapeutics – Phase I Clinical Pipeline 30
5.6.4 Alzheimer’s Disease Therapeutics – Preclinical Pipeline 32
5.6.5 Alzheimer’s Disease Therapeutics – Discovery Pipeline 35
5.7 Discontinued / Suspended Drugs for Alzheimer’s disease 37
5.8 Key Takeaway 40
6 Alzheimer’s Disease Therapeutics: Implications for the Future Market Competition 41
7 Alzheimer’s Disease Therapeutics: Future Players in the Market 43
7.1 Introduction 43
7.2 AstraZeneca 43
7.2.1 Overview 43
7.2.2 Central Nervous System Portfolio 44
7.2.3 Alzheimer’s disease Portfolio 45
7.3 Elan 46
7.3.1 Overview 46
7.3.2 CNS Portfolio 46
7.3.3 Alzheimer’s Disease Product Portfolio 47
7.4 Wyeth (Pfizer) 48
7.4.1 Overview 48
7.4.2 CNS Portfolio 49
7.4.3 Alzheimer’s Disease Product Portfolio 50
7.5 Medivation 52
7.5.1 Overview 52
7.5.2 CNS Portfolio 52
7.5.3 Alzheimer’s Disease Product Portfolio 53
7.6 Baxter Healthcare 53
7.6.1 Overview 53
7.6.2 CNS Portfolio 54
7.6.3 Alzheimer’s Disease Product Portfolio 54
8 Alzheimer’s Disease Therapeutics Market : Appendix 56
8.1 Market Definitions 56
8.2 Scope of Pipeline Research 56
8.3 Abbreviations 56
8.4 Research Methodology 58
8.4.1 Coverage 58
8.4.2 Secondary Research 58
8.4.3 Forecasting 58
8.4.4 Primary Research 61
8.4.5 Expert Panel validation 61
8.5 Contact Us 61
8.6 Disclaimer 61
8.7 Sources 62
ABBREVIATIONS
Browse all : Pharmaceut Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/
Browse all : GlobalData Market
http://www.sandlerresearch.org/publishers/globaldata/
Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports:
Pipeline Insight: Alzheimer's Disease - The ultimate high-risk, high-reward therapy market
http://www.sandlerresearch.org/Reports/8040-pipeline-insight-alzheimers-disease-the-ultimate-high-risk-h.html
Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disease and beyond
http://www.sandlerresearch.org/Reports/8602-pipeline-insight-mild-cognitive-impairment-unlocking-the-poten.html
Global market review of automotive roof systems – forecasts to 2017
http://www.sandlerresearch.org/Reports/17319-global-market-review-of-automotive-roof-systems-forecasts-to-20.html
Inflammatory Bowel Disease Market Forecast
http://www.sandlerresearch.org/Reports/8216-inflammatory-bowel-disease-market-forecast.html
Parkinson's Disease Market Forecast
http://www.sandlerresearch.org/Reports/7889-parkinsons-disease-market-forecast.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/
Original Source : Alzheimer’s Market
http://www.sandlerresearch.org/reports/39674-alzheimers-disease-pipeline-assessment-and-market-forecasts-to.html
Buy Now: Market Research
http://www.sandlerresearch.org/